Sampling endoscopically normal large bowel mucosa from patients presenting with elevated faecal calprotectin levels is not clinically justified.

MLA

Wong, Newton A. C. S., et al. “Sampling Endoscopically Normal Large Bowel Mucosa from Patients Presenting with Elevated Faecal Calprotectin Levels Is Not Clinically Justified.” Journal of Clinical Pathology, vol. 75, no. 3, Mar. 2022, pp. 205–08. EBSCOhost, https://doi.org/10.1136/jclinpath-2020-207343.

APA

Wong, N. A. C. S., Wallage, M. J., Virgo, P., & Lowes, H. (2022). Sampling endoscopically normal large bowel mucosa from patients presenting with elevated faecal calprotectin levels is not clinically justified. Journal of Clinical Pathology, 75(3), 205–208. https://doi.org/10.1136/jclinpath-2020-207343

Chicago

Wong, Newton A. C. S., Michael John Wallage, Paul Virgo, and Hannah Lowes. 2022. “Sampling Endoscopically Normal Large Bowel Mucosa from Patients Presenting with Elevated Faecal Calprotectin Levels Is Not Clinically Justified.” Journal of Clinical Pathology 75 (3): 205–8. doi:10.1136/jclinpath-2020-207343.